← Leaderboards
Anne Radcliff
Cubrc, Inc.
$11,351,418
Attributed
$11,351,418
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $5.8M · FY2011–12$10M$7.5M$5M$2.5M$0
'11
'12
Funding mix
By agency
NIH$11,351,418 · 1
By mechanism
N01$11,351,418 · 1
Top collaborators
No co-investigators on record.
Most similar at Cubrc, Inc.
Same institution · by research overlap
- Anne Kathleen Radcliff$23,902,389
- Trudy Hope Grossman$987,469
- Katie J. Edwards$198,948
- Anders Per Hakansson$198,948
Others in their field
Top investigators on “Advanced Development”
- David Heimbrook · Leidos Biomedical Research, Inc.$625,894,719
- Bambra Strokes · Ppd Development Lp$526,656,217
- Leonard Freedman · Leidos Biomedical Research, Inc.$378,174,673
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$331,630,794
- David H Reitze · University Of Florida$318,606,363
- Albert Lazzarini · California Institute Of Technology$317,303,333
Research focus
Advanced DevelopmentAnti-Bacterial AgentsBacterial PneumoniaBiodefenseCategoriesCommunitiesDrug ResistanceFrancisella TularensisLung DiseasesPathogenPre-ClinicalProduct DevelopmentPublic Health Medicine (Field)Research And DevelopmentRespiratory Tract InfectionsSupport Contracts